Cardiovascular Systems, Inc.: FDA filings under this applicant name

FDA lists 28 510(k) clearances under 2 spellings of the applicant name “Cardiovascular Systems, Inc.” (first 2005, latest 2022), plus 1 PMA decision, across 4 product codes in 1 review panel. Median 510(k) review time under this name: 48 days. Since 2017 the median was 60 days, against 100 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.

510(k) clearances per year

YearClearancesMedian review days
2012129
2013116
2014163
2015227
20160—
2017185
2018361
20191112
2020250
2021530
2022147
20230—
20240—
20250—
20260—

Review time against the same product codes

Since 2017, 510(k)s cleared under the name Cardiovascular Systems, Inc. took a median 60 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 100 days.

Top product codes

Product codeDeviceSubmissions510(k) clearances
MCWCatheter, Peripheral, Atherectomy2121
DQYCatheter, Percutaneous55
NTETemporary Carotid Catheter For Embolic Capture22
MCXCatheter, Coronary, Atherectomy10

Review panels

Most recent Cardiovascular Systems, Inc. 510(k) clearances

510(k)DeviceProduct codeDecision dateReview days
K220109DIAMONDBACK 360 Peripheral Orbital Atherectomy System, DIAMONDBACK 360 Peripheral Orbital Atherectomy System, Exchangeable Series, Stealth 360 Peripheral Orbital Atherectomy SystemMCW2022-03-0147
K212725ViperCross Support CathetersDQY2021-09-2428
K210586Diamonback 360 Peripheral Orbital Atherectomy System, Diamondback 360 Stealth Orbital Atherectomy systemMCW2021-09-14200
K211240ViperCross Support CathetersDQY2021-08-26122
K211251ViperCath XC Peripheral Exchange CatheterDQY2021-05-2630
K210282WIRION Embolic Protection SystemNTE2021-03-0330
K203008DIAMONDBACK 360 Peripheral Orbital Atherectomy System, DIAMONDBACK 360 Peripheral Orbital Atherectomy System, Exchangeable Series, Stealth 360 Peripheral Orbital Atherectomy SystemMCW2020-11-1949
K200198WIRIONNTE2020-03-1851
K190634Diamondback 360 Peripheral Orbital Atherectomy System, Stealth 360 Peripheral Orbital Atherectomy SystemMCW2019-07-02112
K183000ViperCath XC Peripheral Exchange CatheterDQY2018-12-2960

18 earlier clearances. See the full list in Caduvo.

PMA and De Novo decisions

NumberPathwayDeviceDecision date
P130005PMADIAMONDBACK 360 CORONARY ORBITAL ATHERECTOMY SYSTEM2013-10-21

Recalls

17 product recalls in 15 recall events; 1 initiated in the last five years. Most recent: 2021-11-22.

Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.

FDA spellings included

FDA records this applicant under 2 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:

Other FDA applicant names starting with the same word

FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.

Frequently asked questions

How many FDA 510(k) clearances are listed under Cardiovascular Systems, Inc.?

FDA lists 28 510(k) clearances under 2 spellings of the applicant name “Cardiovascular Systems, Inc.” (first 2005, latest 2022), plus 1 PMA decision, across 4 product codes in 1 review panel. Filings under other applicant names, such as subsidiaries, are not included.

How long has FDA taken to clear 510(k)s filed by Cardiovascular Systems, Inc.?

The median time from FDA receipt to decision across 510(k)s cleared under the name Cardiovascular Systems, Inc. is 48 days. Since 2017: 60 days, versus 100 days for all cleared 510(k)s in the same product codes.

Which FDA product codes appear under Cardiovascular Systems, Inc.?

The most frequent FDA product codes under this applicant name are MCW (Catheter, Peripheral, Atherectomy, 21); DQY (Catheter, Percutaneous, 5); NTE (Temporary Carotid Catheter For Embolic Capture, 2).

Next steps

Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.

All FDA device companies · FDA product code lookup